KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists

Renalytix PLC (LSE: RENX) (OTCQB: RNLXY), a precision medicine diagnostics company, today announced results published in the ...
Medical Xpress

Disagreement between two kidney function tests predicts serious health problems

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study shows. Health care providers for decades have measured ...

Renalytix shares climb 24% as two-year kidney study data published

Shares in Renalytix PLC (AIM:RENX, OTC:RNLXY, FRA:2O9) climbed 24% to 2.35p after the precision diagnostics company published ...
University of California, San Francisco

Genetic Test Ranks Risk for Black People Hoping to Donate a Kidney

A UCSF study followed Black kidney donors to see if they faced elevated risks for low kidney function, and found that many ...